. Author manuscript; available in PMC: 2024 Mar 23.

Published in final edited form as: J Clin Psychiatry. 2023 May 22;84(4):22m14611. doi: 10.4088/JCP.22m14611

Table 2.

Correlates of suicidal ideation at intake

	Unadjusted odds ratios		Adjusted odds ratios

	OR (95% CI)	p-value	aOR (95% CI)	p-value
*Demographics*
Female gender^b	1.46 (1.34-1.59)	<.001*	1.08 (0.98-1.19)	.134
Age	0.98 (0.98-0.98)	<.001*	0.99 (0.99-0.997)	.001*
Primary Substance^c
Marijuana	1.97 (1.65-2.34)	<.001*	1.73 (1.40-2.15)	<.001*
Opioids/heroin	1.38 (1.24-1.54)	<.001*	1.27 (1.11-1.44)	<.001*
Cocaine	1.59 (1.36-1.89)	<.001*	1.48 (1.23-1.79)	<.001*
Other stimulants	1.84 (1.60-2.12)	<.001*	1.43(1.21-1.69)	<.001*
Benzodiazepines	1.71 (1.37-2.12)	<.001*	1.15 (0.90-1.49)	.266
Other	1.73 (1.41-2.13)	<.001*	1.30 (1.02-1.66)	.036*
*Chronic health*
Chronic Pain^d	1.51 (1.38-1.64)	<.001*	1.09 (0.98-1.21)	.107
Hepatitis C^d	1.65 (1.26-2.17)	<.001*	1.18 (0.86-1.62)	.307
HIV/AIDS^d	1.56 (0.96-2.53)	.074	1.09 (0.62-1.92)	.771
*Psychiatric comorbidity*
Positive depression screen^e	6.98 (6.22-7.84)	<.001*	3.65 (3.18-4.20)	<.001*
Positive anxiety screen^e	4.24 (3.85-4.68)	<.001*	1.39 (1.22-1.58)	<.001*
Positive PTSD screen^e	4.69 (4.26-5.16)	<.001*	2.00 (1.77-2.24)	<.001*
*Past self-harm/suicide behavior*
Self-harm (Past 30 Days)^d	11.21 (8.78-14.30)	<.001*	4.71 (3.58-6.20)	<.001*
Lifetime suicide attempt^d	8.19 (7.20-9.31)	<.001*	5.03 (4.36-5.79)	<.001*

^a.

Nagelkerke R²= 0.34, Correct classification = 0.72, Sensitivity = 0.72, Specificity = 0.71, F-score = 0.64;

^c.

Ref = Not female

^d.

Ref = Alcohol

^b.

Ref= Did not endorse

^e.

Ref= Screened negative